Jazz Pharmaceuticals (JAZZ) EPS (Basic) (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) recorded quarterly EPS (Basic) of $4.73 in Q1 2026, up 41.62% quarter-over-quarter from $3.34 in Q4 2025, and up 411.18% on a YoY basis from $0.93 in Q1 2025.
Jazz Pharmaceuticals (JAZZ) EPS (Basic) (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at $4.73 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 411.18% year-over-year to $4.73; the TTM figure through Mar 2026 stood at $0.47 (down 93.97% YoY), while the FY2025 annual figure was -$5.84, down 164.46% from the prior year.
- EPS (Basic) was $4.73 for Q1 2026 at Jazz Pharmaceuticals, up from $3.34 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $4.73 in Q1 2026 to a low of -$11.74 in Q2 2025.
- Historically, EPS (Basic) has averaged $0.65 across 5 years, with a median of $1.5 in 2023.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 612.96% in 2022, then jumped 3533.33% in 2023.
- A 5-year view of EPS (Basic) shows it stood at -$3.85 in 2022, then soared by 138.96% to $1.5 in 2023, then surged by 108.67% to $3.13 in 2024, then gained by 6.71% to $3.34 in 2025, then soared by 41.62% to $4.73 in 2026.
- The last three EPS (Basic) figures came in at $4.73 (Q1 2026), $3.34 (Q4 2025), and $4.14 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | 4.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.73 |
| Dec 31, 2025 | 3.34 |
| Sep 30, 2025 | 4.14 |
| Jun 30, 2025 | -11.74 |
| Mar 31, 2025 | -1.52 |
| Dec 31, 2024 | 3.13 |
| Sep 30, 2024 | 3.50 |
| Jun 30, 2024 | 2.68 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | 1.50 |
| Sep 30, 2023 | 2.33 |
| Jun 30, 2023 | 1.63 |
| Mar 31, 2023 | 1.09 |
| Dec 31, 2022 | -3.85 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | 0.56 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.86 |
| Jun 30, 2021 | -6.11 |